Study identifies new concepts for GLP-1 action in the brain
Researcher Dr. Daniel Drucker has much to be proud of, as the GLP-1-based diabetes drugs hailing from his early research are named the 2023 breakthrough of the year by the Science Magazine. Not only have millions of people ...
Dec 18, 2023
0
30